出处
《中国综合临床》
北大核心
2005年第8期761-762,共2页
Clinical Medicine of China
基金
广东省科技厅基金科技计划基金(2003C33801)
参考文献19
-
1Oliveri RL,Valentino P,Russo C,et al.Randomized trial comparing two different high doses of methylprednisolone in MS:a clinical and MRI study[J].Neurology,1998,50(6):1 833-1 836.
-
2Zivadinov R,Rudick RA,De Masi R,et al.Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS[J].Neurology,2001,57(7):1 239-1 247.
-
3Goodkin DE,Kinkel RP,Weinstock-Guttman B,et al.A phase II study of iv methylprednisolone in secondary-progressive multiple sclerosis[J].Neurology,1998,51(1):239-245.
-
4The PRISMS Study Group and the University of British Columbia MS/MRI Analysis Group.PRISMS-4:Long-term efficacy of interferon-beta-1a in relapcing MS[J].Neurology,2001,56(12):1 628-1 636.
-
5Clanet M,Radue EW,Kappos L,et al.A randomized,double-blind,dose-comparison study of weekly interferon beta-1a in relapsing MS[J].Neurology,2002,59(10):1 507-1 517.
-
6PRISMS(Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis)Study Group.Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis[J].Lancet,1998,352(9 139):1 498-1 504.
-
7Panitch H,Goodin DS,Francis G,et al.Randomized,comparative study of interferon beta-1a treatment regimens in MS:The EVIDENCE Trial[J].Neurology,2002,59(10):1 496-1 506.
-
8Li DK,Zhao GJ,Paty DW,et al.Randomized controlled trial of interferon-beta-1a in secondary progressive MS:MRI results[J].Neurology,2001,56(11):1 505-1 513.
-
9European study group on interferon β-1b in secondary progressive MS.Placebo-controlled multicentre randomized trial of interferon β-1b in treatment of secondary progressive multiple sclerosis[J].Lancet,1998,352(9 139):1 491-1 497.
-
10Leary SM,Miller DH,Stevenson VL,et al.Interferon beta-1a in primary progressive MS:an exploratory,randomized,controlled trial[J].Neurology,2003,60(1):44-51.
同被引文献16
-
1彭静婷,张晓君,高玉红,孙厚亮,孙彦斌,路阳,赤克美.视神经炎和早期多发性硬化患者的认知损害研究[J].首都医科大学学报,2010,31(2):166-171. 被引量：8
-
2赵顺珍,赵薛旭.早发性多发性硬化32例[J].实用儿科临床杂志,1997,12(1):10-13. 被引量：3
-
3中华医学会神经病学分会神经免疫学组.中国免疫学会神经免疫分会,中国多发性硬化诊断和治疗专家共识[J].中华神经科杂志,2010,:43-521,516.
-
4Friese MA,Montalban X,Willcox N,et al.The value of ani-mal models for drug development in multiple sclerosis[J].Brain,2006,129(8):1940-1952.
-
5李凤鸣.眼科全书:下册[M]北京:人民卫生出版社,19963168.
-
6万国兰;方桂远;吴丽.实用小儿神经疾病学[M]郑州:河南医科大学出版社,1997128-129.
-
7Soderstrom M. Multiple sclerosis:rationale for early treatment[J].Neurological Sciences,2003,(Suppl 5):S298-S300.
-
8Soderstrom M. Optic neuritis and multiple sclerosis[J].Acta Ophthalmologica Scandinavica,2001,(03):223-227.
-
9郭硕,魏世辉.多发性硬化患者发生视神经炎34例的回顾性分析[J].国际眼科杂志,2008,8(2):333-335. 被引量：10
-
10张海燕.多发性硬化的磁共振成像诊断[J].医学理论与实践,2008,21(12):1399-1401. 被引量：4
-
1孟丽莉,殷春梅,徐辉,王虹,杨坤,李晓霞.阿加曲班联合舒血宁治疗急性脑梗死的有效性和安全性研究[J].牡丹江医学院学报,2010,31(4):34-36. 被引量：7
-
2金淑梅,廖亚丽等.中枢神经脱髓鞘疾病－胼胝体变性1例[J].吉林医学信息,2001,18(11):33-33.
-
3马振兴.系统性红斑狼疮伴脊髓型多发性硬化1例[J].华西医学,2005,20(4):764-764.
-
4陈青,郭娟.多发性硬化症复发的诱因及预防[J].中日友好医院学报,2003,17(3):192-192.
-
5邹靖锋,谢珂,郭培燕,董绪帅,赵霏.针刺治疗阿尔茨海默病临床随机对照试验Meta分析[J].西部中医药,2016,29(1):80-84. 被引量：9
-
6秦志慧.尿激酶与低分子肝素联用治疗急性脑梗死疗效观察[J].中原医刊,2003,30(10):42-43. 被引量：2
-
7赵新惠,刘秀珍,庞江霞.血清水通道蛋白4抗体检测在中枢神经脱髓鞘疾病中的临床意义[J].中外女性健康研究,2016(7):196-196. 被引量：1
-
8陈晨,李伟荣,柳青.脑N-乙酰-L-天冬氨酸浓度下降可以预测复发缓解型多发性硬化进展情况[J].中华医学杂志,2012,92(27):1904-1904.
-
9任晓威,薛晓文.治疗多发性硬化症的选择性鞘胺醇-1-磷酸受体1激动剂的临床研究进展[J].临床合理用药杂志,2014,7(17):170-172. 被引量：1
-
10曹嵘.眼部症状为突出表现的23例儿童中枢神经脱髓鞘疾病分析[J].中国实用神经疾病杂志,2008,11(6):36-37.
